Andy Slaughter – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Andy Slaughter on 2016-10-11.

To ask the Secretary of State for Health, what new treatments for Duchenne muscular dystrophy have been notified to the Horizon Scanning Research and Intelligence Centre in the last 12 months.

Nicola Blackwood

In the last 12 months, the National Institute for Health Research Horizon Scanning Research and Intelligence Centre has identified and added to its database the following technologies for which Duchenne muscular dystrophy is an indication:

– ezutromid;

– FG-3019;

– follistatin;

– halofuginone hydrobromide;

– SRP-4045;

– SRP-4053; and

– vamorolone.